Beth Israel Deaconess Medical Center Cancer Center — Boston, Massachusetts

Beth Israel Deaconess Medical Center Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Medical Center Cancer Center has participated in 1 clinical trials.

Therapeutic areas: HER2-positive Breast Cancer, HER2 Gene Mutation, HER-2 Gene Amplification.

Sponsors: Klus Pharma Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Medical Center Cancer Center?

Beth Israel Deaconess Medical Center Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Medical Center Cancer Center conducted?

Beth Israel Deaconess Medical Center Cancer Center has 1 clinical trials on record. Their work covers HER2-positive Breast Cancer, HER2 Gene Mutation, HER-2 Gene Amplification.

Is Beth Israel Deaconess Medical Center Cancer Center accredited by Crixeo Health?

Beth Israel Deaconess Medical Center Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess Medical Center Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.